The company boasts a research and development laboratory and a GMP level clean workshop of 3200m², which includes a cell separation magnetic beads development platform, eukaryotic and prokaryotic protein expression engineering platform, and serum-free medium development platform. In addition, Beijing Chuanyi Biotechnology Co., Ltd. is in conformity with both ISO13485 and ISO9001 Quality Management System Standard, and some products have been FDA DMF filed.
With an impressive array of products and a strong dedication to quality and innovation, the company is positioned as a top contender in the field of clinical research and trial management. By leveraging their expertise and state-of-the-art facilities, they are well-equipped to provide the necessary materials and support for cutting-edge cell and gene therapy research.
A key point to highlight is the company's focus on GMP-grade raw materials and reagents for CGT, catering to the growing demand in the field of cell and gene therapy. This niche specialization allows them to provide comprehensive solutions for customers in this rapidly evolving sector.
In addition, the company's extensive facilities and adherence to quality management standards demonstrate their commitment to ensuring the highest level of product quality and safety. This is essential in the development of materials and reagents for use in clinical trials and ultimately, in the treatment of patients.
The company's FDA DMF filed products further underscore their dedication to meeting regulatory standards and providing products that meet the highest levels of safety and efficacy.
Overall, Beijing Chuanyi Biotechnology Co., Ltd. is a standout player in the clinical research organization space, offering top-rated expertise in clinical trials management. With a strong emphasis on quality, innovation, and specialization in GMP-grade raw materials and reagents for CGT, they are well-positioned to meet the evolving needs of the industry and support advancements in cell and gene therapy research.